Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bio Rad Laboratories Inc BIO

Alternate Symbol(s):  BIO.B

Technology Scientific & Technical Instruments
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and... see more

Recent & Breaking News (NYSE:BIO)

Bio-Rad's Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference

Business Wire 2 days ago

Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference

Business Wire October 31, 2024

Bio-Rad Reports Third-Quarter 2024 Financial Results

Business Wire October 30, 2024

Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024

Business Wire October 14, 2024

Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

PR Newswire September 6, 2024

Bio-Rad's Management to Participate in Fireside Chat During Wells Fargo's 2024 Healthcare Conference

Business Wire August 22, 2024

Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer

Business Wire August 20, 2024

Bio-Rad Reports Second-Quarter 2024 Financial Results

Business Wire August 1, 2024

Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024

Business Wire July 17, 2024

Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group

Business Wire May 30, 2024

Bio-Rad's Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference

Business Wire May 23, 2024

Bio-Rad Reports First-Quarter 2024 Financial Results

Business Wire May 7, 2024

Bio-Rad's Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference

Business Wire May 1, 2024

Bio-Rad Announces Life Science Group Management Changes

Business Wire April 26, 2024

Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024

Business Wire April 18, 2024

Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay

GlobeNewswire April 11, 2024

Bio-Rad's Chief Operating Officer Andrew Last to Retire

Business Wire April 10, 2024

Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer

Business Wire March 20, 2024

Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day

Business Wire February 22, 2024

Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results

Business Wire February 15, 2024